These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 20931671)

  • 21. [Penicillin G and erysipelas--still being used?].
    Graninger W
    J Dtsch Dermatol Ges; 2005 Apr; 3(4):245-6. PubMed ID: 16370471
    [No Abstract]   [Full Text] [Related]  

  • 22. Antibiotic use in patients with erysipelas: a retrospective study.
    Bishara J; Golan-Cohen A; Robenshtok E; Leibovici L; Pitlik S
    Isr Med Assoc J; 2001 Oct; 3(10):722-4. PubMed ID: 11692544
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diagnostic value of laboratory parameters for the discrimination between erysipelas and limited cellulitis.
    Drerup C; Eveslage M; Sunderkoetter C; Ehrchen J
    J Dtsch Dermatol Ges; 2020 Dec; 18(12):1417-1424. PubMed ID: 33035396
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Bacterial acute non necrosing cellulitis (erysipelas) in adult].
    Dezoteux F; Staumont-Sallé D
    Rev Med Interne; 2021 Mar; 42(3):186-192. PubMed ID: 33176944
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Cellulitis: clinical manifestations and management].
    Blum CL; Menzinger S; Genné D
    Rev Med Suisse; 2013 Oct; 9(401):1812-5. PubMed ID: 24191414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Recurrent erysipelas: 47 cases.
    Leclerc S; Teixeira A; Mahé E; Descamps V; Crickx B; Chosidow O
    Dermatology; 2007; 214(1):52-7. PubMed ID: 17191048
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Erysipelas after breast cancer treatment (26 cases).
    Masmoudi A; Maaloul I; Turki H; Elloumi Y; Marrekchi S; Bouassida S; Ben Jemaa M; Zahaf A
    Dermatol Online J; 2005 Dec; 11(3):12. PubMed ID: 16409908
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Effect of sodium nucleinate on the effectiveness of antibiotic therapy of erysipelas].
    Frolov VM; Rychnev VE; Peresadin NA
    Antibiotiki; 1984 Feb; 29(2):132-5. PubMed ID: 6703667
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Cyclical intravenous antibiosis as an effective therapy concept in chronic recurrent erysipelas].
    Allard P; Stücker M; von Kobyletzki G; el Gammal S; Altmeyer P
    Hautarzt; 1999 Jan; 50(1):34-8. PubMed ID: 10068929
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Risk factors for abscess formation in patients with superficial cellulitis (erysipelas) of the leg.
    Picard D; Klein A; Grigioni S; Joly P
    Br J Dermatol; 2013 Apr; 168(4):859-63. PubMed ID: 23210619
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The prevention of recurrent erysipelas].
    van Furth R
    Ned Tijdschr Geneeskd; 1992 Oct; 136(42):2049-51. PubMed ID: 1407204
    [No Abstract]   [Full Text] [Related]  

  • 32. [Erysipelas without fever or biologic inflammation during tocilizumab therapy].
    Yéléhé-Okouma M; Henry J; Petitpain N; Schmutz JL; Gillet P
    Ann Dermatol Venereol; 2017; 144(6-7):434-437. PubMed ID: 28396064
    [TBL] [Abstract][Full Text] [Related]  

  • 33. What factors affect the length of hospitalization in patients with erysipelas? A 10-year retrospective study of patients hospitalized in Lower Silesia, Poland.
    Łyko M; Kaczmarek M; Nekrasova P; Hryncewicz-Gwóźdź A; Maj J; Jankowska-Konsur A
    Adv Clin Exp Med; 2021 Sep; 30(9):981-985. PubMed ID: 34410045
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Risk factors associated with a reduced response in the treatment of erysipelas.
    Linke M; Booken N
    J Dtsch Dermatol Ges; 2015 Mar; 13(3):217-25. PubMed ID: 25706926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Meta-analysis of randomised trials comparing a penicillin or cephalosporin with a macrolide or lincosamide in the treatment of cellulitis or erysipelas.
    Ferreira A; Bolland MJ; Thomas MG
    Infection; 2016 Oct; 44(5):607-15. PubMed ID: 27085865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Benzathine penicillin G once-every-3-week prophylaxis for recurrent erysipelas a retrospective study of 132 patients.
    Rob F; Hercogová J
    J Dermatolog Treat; 2018 Feb; 29(1):39-43. PubMed ID: 28489486
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic image (180). A woman with painful erythema after breast -conserving surgery. Erysipelas caused by group B Streptococcus agalactiae].
    van den Wildenberg FJ; Strobbe LJ
    Ned Tijdschr Geneeskd; 2004 Mar; 148(11):524. PubMed ID: 15054951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intramuscular bipenicillin vs. intravenous penicillin in the treatment of erysipelas in adults: randomized controlled study.
    Zeglaoui F; Dziri C; Mokhtar I; Ezzine N; Kharfi M; Zghal M; Fazaa B; Kamoun MR
    J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):426-8. PubMed ID: 15196155
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic antibiotics in erysipelas.
    Duvanel T; Mérot Y; Harms M; Saurat JH
    Lancet; 1985 Jun; 1(8442):1401. PubMed ID: 2861358
    [No Abstract]   [Full Text] [Related]  

  • 40. [Therapy and prophylaxis of recurrent erysipelas (author's transl)].
    Ziebart-Schroth A
    Med Klin; 1976 Jul; 71():1197-9. PubMed ID: 822266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.